Shannon Campbell

Shannon Campbell

Director/Board Member at BLACK DIAMOND THERAPEUTICS, INC.

Net worth: 16 711 $ as of 30/09/2026

60 year
Health Technology
Consumer Services

Profile

Ms. Shannon Campbell is an Independent Director at Black Diamond Therapeutics, Inc. She is on the Board of Directors at Hansa Biopharma AB, Zentalis Pharmaceuticals, Inc. and Black Diamond Therapeutics, Inc. Ms. Campbell was previously employed as a Chief Commercial Officer & Executive VP by Merus NV and a Vice President & General Manager-Oncology by Bayer HealthCare Pharmaceuticals, Inc. She received her undergraduate degree from Ithaca College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/06/2026 8,865 ( 0.02% ) 16 711 $ 30/09/2026

Shannon Campbell active positions

CompaniesPositionStart
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 10/04/2024
ZENTALIS PHARMACEUTICALS, INC. Director/Board Member 22/05/2026
HANSA BIOPHARMA AB Director/Board Member 22/09/2026

Former positions of Shannon Campbell

CompaniesPositionEnd
MERUS N.V. Corporate Officer/Principal 01/01/2026
Corporate Officer/Principal 01/01/2017
See the detail of Shannon Campbell's experience

Education of Shannon Campbell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

59

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Shannon Campbell